CONMED Corporation (CNMD)

Net profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands 64,459 57,972 88,285 -93,738 -80,582 -82,722 -113,924 67,657 62,542 62,238 54,140 13,450 9,517 310 430 33,525 28,619 29,339 28,194 31,218
Revenue (ttm) US$ in thousands 1,244,743 1,168,565 1,139,075 1,098,613 1,045,472 1,068,575 1,042,314 1,020,285 1,010,635 989,493 978,501 881,125 862,458 874,495 870,250 950,728 955,096 932,675 901,392 875,949
Net profit margin 5.18% 4.96% 7.75% -8.53% -7.71% -7.74% -10.93% 6.63% 6.19% 6.29% 5.53% 1.53% 1.10% 0.04% 0.05% 3.53% 3.00% 3.15% 3.13% 3.56%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $64,459K ÷ $1,244,743K
= 5.18%

The net profit margin of Conmed Corp. has exhibited variability over the past eight quarters. In Q4 2023, it stood at 5.18%, showing a slight improvement from the previous quarter's 4.96%. The Q2 2023 net profit margin reached 7.75%, demonstrating a significant increase compared to the preceding quarters. However, in Q1 2023, the company experienced a negative net profit margin of -8.53%, indicating that expenses exceeded revenues during that period.

Looking back to Q4 2022 and Q3 2022, the net profit margins were negative at -7.71% and -7.74% respectively, with the situation worsening in Q2 2022 to -10.93%. This negative trend reversed in Q1 2022, where a positive net profit margin of 6.63% was achieved, signifying a profitable period for the company.

Overall, Conmed Corp.'s net profit margin has been volatile, with periods of profitability interspersed with losses. It is crucial for the company to closely monitor its expenses and revenue generation to sustain or improve its profitability levels in the future.


Peer comparison

Dec 31, 2023